No Data
No Data
Dow Dips Over 300 Points; Viad Shares Spike Higher
IGM Biosciences Is Maintained at Outperform by RBC Capital
RBC Capital Maintains IGM Biosciences(IGMS.US) With Buy Rating, Raises Target Price to $20
Analysts' Top Healthcare Picks: Intuitive Surgical (ISRG), IGM Biosciences (IGMS)
Express News | IGM Biosciences Inc : RBC Raises Target Price to $20 From $17
PepsiCo, DocuSign, Robinhood And Other Big Stocks Moving Higher On Tuesday